Publications by authors named "Andrew A Protter"

Claim this Profile
E
Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses.
Zhewei Shen, Anna Halberg, Jia Yi Fong, Jingyu Guo, Gavin Song, Andrew A Protter

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restricted Delivery of Talazoparib Across the Blood-Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma.
Sani H Kizilbash, Shiv K Gupta, Kenneth Chang, Ryo Kawashima, Karen E Parrish, Andrew A Protter

Mol Cancer Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of pyrazolopyrimidine derivatives as novel inhibitors of ataxia telangiectasia and rad3 related protein (ATR).
Sreekanth A Ramachandran, Pradeep S Jadhavar, Manvendra P Singh, Ankesh Sharma, Gaurav N Bagle, Andrew A Protter

Bioorg Med Chem Lett· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide analogs with improved brain/plasma ratios - Exploring the possibility of enhancing the therapeutic index of temozolomide.
Roopa Rai, Monali Banerjee, Darren H Wong, Emma McCullagh, Ashu Gupta, Andrew A Protter

Bioorg Med Chem Lett· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.
Dawn R Cochrane, Sebastián Bernales, Britta M Jacobsen, Diana M Cittelly, Erin N Howe, Andrew A Protter

Breast Cancer Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer.
Javier Guerrero, Iván E Alfaro, Francisco Gómez, Andrew A Protter, Sebastián Bernales

Prostate· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical alpha-selective p38 MAP kinase inhibition reduces acute skin inflammation in guinea pig.
Satyanarayana Medicherla, Jing Ying Ma, Mamtha Reddy, Irina Esikova, Irene Kerr, Andrew A Protter

J Inflamm Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognition-enhancing properties of Dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonism.
Marco Giorgetti, Jacqueline A Gibbons, Sebastián Bernales, Iván E Alfaro, Christophe Drieu La Rochelle, Andrew A Protter

J Pharmacol Exp Ther· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of B-type natriuretic peptide infusion after acute myocardial infarction in a rat model.
Isaac George, Steve Xydas, Stefan Klotz, Ilan Hay, Chuck Ng, Andrew A Protter

J Cardiovasc Pharmacol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of defective B-type natriuretic peptide.
Santosh G Menon, Roger M Mills, Ute Schellenberger, Syed Saqhir, Andrew A Protter

Clin Cardiol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged effects of B-type natriuretic peptide infusion on cardiac remodeling after sustained myocardial injury.
Isaac George, Brad Morrow, Kai Xu, Geng-Hua Yi, Jeffrey Holmes, Andrew A Protter

Am J Physiol Heart Circ Physiol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p38 MAPK inhibition reduces diabetes-induced impairment of wound healing.
Satyanarayana Medicherla, Scott Wadsworth, Breda Cullen, Derek Silcock, Jing Y Ma, Andrew A Protter

Diabetes Metab Syndr Obes· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p38alpha-selective MAP kinase inhibitor reduces tumor growth in mouse xenograft models of multiple myeloma.
Satyanarayana Medicherla, Mamatha Reddy, Jing Ying, Tony A Navas, Lingyun Li, Andrew A Protter

Anticancer Res· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective p38α mitogen-activated protein kinase inhibitor attenuates lung inflammation and fibrosis in IL-13 transgenic mouse model of asthma.
Jing Ying Ma, Satyanarayana Medicherla, Irene Kerr, Ruban Mangadu, Andrew A Protter

J Asthma Allergy· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming growth factor-beta blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarction.
Leigh J Ellmers, Nicola J A Scott, Satyanarayana Medicherla, Anna P Pilbrow, Paul G Bridgman, Andrew A Protter

Endocrinology· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.
Eric E Niederkofler, Urban A Kiernan, Jessica O'Rear, Santosh Menon, Syed Saghir, Andrew A Protter

Circ Heart Fail· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of p38 mitogen activated protein kinase in a model of osteosarcoma-induced pain.
Camilla I Svensson, Satyanarayana Medicherla, Shelle Malkmus, Yebin Jiang, Jing Y Ma, Andrew A Protter

Pharmacol Biochem Behav· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological properties of SD-282 - an alpha-isoform selective inhibitor for p38 MAP kinase.
Bruce Koppelman, Heather K Webb, Satyanarayana Medicherla, Ramona Almirez, Ying Feng, Andrew A Protter

Pharmacology· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation.
Satyanarayana Medicherla, Mary F Fitzgerald, Dianne Spicer, Paul Woodman, Jing Y Ma, Andrew A Protter

J Pharmacol Exp Ther· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
Satyanarayana Medicherla, Lingyun Li, Jing Ying Ma, Ann M Kapoun, Nicholas J Gaspar, Andrew A Protter

Anticancer Res· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia.
Zhihe Li, Ying Zhang, Jing Ying Ma, Ann M Kapoun, Qiming Shao, Andrew A Protter

Hypertension· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-Type natriuretic peptide inhibited angiotensin II-stimulated cholesterol biosynthesis, cholesterol transfer, and steroidogenesis in primary human adrenocortical cells.
Faquan Liang, Ann M Kapoun, Andrew Lam, Debby L Damm, Diana Quan, Andrew A Protter

Endocrinology· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
Thomas-Toan Tran, Martin Uhl, Jing Ying Ma, Lisa Janssen, Venkataraman Sriram, Andrew A Protter

Neuro Oncol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of p38alpha mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myeloma.
Karin Vanderkerken, Satya Medicherla, Les Coulton, Hendrik De Raeve, Angelo Willems, Andrew A Protter

Cancer Res· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for functional heterogeneity of circulating B-type natriuretic peptide.
Faquan Liang, Jessica O'Rear, Ute Schellenberger, Lungkuo Tai, Michael Lasecki, Andrew A Protter

J Am Coll Cardiol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis